|
AstraZeneca Pharma India Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
22887.50 Cr.
|
P/BV
|
33.69
|
Book Value (Rs.)
|
271.74
|
|
52 Week High/Low (Rs.)
|
10691/6313
|
FV/ML
|
2/1
|
P/E(X)
|
197.75
|
|
Bookclosure
|
18/07/2025
|
EPS (Rs.)
|
46.30
|
Div Yield (%)
|
0.35
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 156.36 | 219.54 | 134.10 | 83.04 | 127.09 |
| | | | | | |
| Net CashFlow From Operating Activities | 65.36 | 27.87 | 58.29 | 100.80 | 104.78 |
| Net Cash Used In Investing Activities | 30.80 | 21.74 | 18.11 | 4.74 | 173.03 |
| Net Cash Used From Financing Activities | -65.59 | -44.38 | -24.48 | -9.46 | -8.97 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 30.57 | 5.23 | 51.92 | 96.08 | 268.84 |
| Cash And Cash Equivalents Begin of Year | 505.57 | 500.34 | 448.42 | 352.34 | 83.50 |
| Cash And Cash Equivalents End Of Year | 536.14 | 505.57 | 500.34 | 448.42 | 352.34 |